Information
Considering RADICAVA®?
Get your questions answered.
Learn more
Call a RADICAVA®
JourneyMate today.
1-855-457-6968
Call

Get answers about starting RADICAVA®
Call 1-855-4-JRNY-M8 (1-855-457-6968)

Close

Product Access Program

To learn more, call
1-844-SRCHLGT (1-844-772-4548)

We're here for you

Searchlight Support® provides education and assistance for people who receive RADICAVA® (edaravone) and those who care for them. Our Care Coordinators are ready to help.

Cost Support Options

Out-of-Pocket Cost Support Options
We can help you obtain co-pay assistance, if eligible

Infusion Center Directory

ALS Care Locator
Locate services for the treatment of ALS

How to enroll in Searchlight Support®

To be enrolled in Searchlight Support®, your healthcare provider (HCP) must prescribe RADICAVA® for you. You will also need to provide authorization for enrollment in the program by reading and signing one of these forms:

  • The form your HCP submits the first time they order RADICAVA® for you (a Benefit Investigation and Enrollment Form), or
  • A separate Patient Authorization Form
3 ways to submit your signed Patient Authorization Forma
DocuSign Icon
Electronically with DocuSign®
Access your Patient Authorization Form on your phone, tablet, or computer here. Simple prompts will guide you to read, electronically sign, and submit your form.
Fax Icon
By Fax
Download, print, and sign your Patient Authorization Form (available here) and fax it to 1-888-782-6157. Searchlight Support® accepts both traditional fax and electronic faxes.
Mail Icon
By Mail
Download, print, and sign your Patient Authorization Form (available here) and mail it to:
Searchlight Support®
PO Box 2930
Phoenix, AZ 85062

If you have any questions about how to submit your signed form, call Searchlight Support® at 1-844-772-4548.

Once you are enrolled in Searchlight Support®, one of our Care Coordinators will be assigned to assist you and will reach out to offer care coordination and out-of-pocket cost support options that may be available to you.

The Patient Authorization Form is not the same as a prescription. Enrollment in Searchlight Support® also requires your healthcare provider to submit a RADICAVA® Benefit Investigation and Enrollment Form for you.

aMitsubishi Tanabe Pharma America, Inc. ("MTPA") is not affiliated with DocuSign® or any electronic fax service providers (collectively, "service providers"). No fees or remuneration of any kind have been or will be exchanged with any healthcare provider for use of these service providers. Mention of these service providers does not constitute a referral, recommendation, endorsement of a particular service provider, and similarly, the absence of a service provider's name should not be construed as a negative comment from MTPA about that service provider. MTPA, as well as its employees or agents, shall not be held liable for any damages or harm resulting from any use or reliance on these service providers, and MTPA may modify its policy regarding these service providers at any time without notice.

Out-of-Pocket Cost Support Options

We understand that serious medical conditions place a financial burden on many families. That’s why Searchlight Support® helps to provide affordable access to RADICAVA®.

Our dedicated Searchlight Support® Care Coordinators can help you navigate cost support options that may be available to you. But first, you may want to learn about some of these options below.

Out-of-Pocket Assistance Program
Support for eligible patients with commercial insurance

Eligible, commercially insured patients may be automatically enrolled when their healthcare provider submits a Benefit Investigation and Enrollment Form for RADICAVA®.

If you are enrolled in the program, you will:

  • Save on your deductible, co-pay, and co-insurance costs for RADICAVA® and for your infusionsb
  • Pay as little as $0 per infusion
  • Your applicable out-of-pocket costs are covered–up to $20,000 per calendar yearc
  • Automatic re-enrollment for the next calendar year, if eligible

Assistance is not valid for patients covered, in whole or in part, by government-funded health insurance such as Medicare, Medicare Part D, or Medicaid.

bPersons residing in Massachusetts, Minnesota, Michigan, and Rhode Island are eligible for out-of-pocket assistance for the cost of the drug only and are not eligible for other types of cost support for administration of the medication.

cYou will be responsible for any costs associated with RADICAVA® and your infusion above the maximum annual program benefit.

A program designed to help with treatment costs

Your personalized program card will be used by your infusion provider to submit reimbursement claims to the Searchlight Support® Out-of-Pocket Assistance Program (the Program).

IMPORTANT!
Please make sure to bring your program card to all of your treatment appointments.

Copay Card
How this program works

At enrollment, Searchlight Support® will:

  • Review your insurance benefits to determine your out-of-pocket costs, and confirm your eligibility for the Program, including verifying commercial insurance
  • Call to explain your insurance benefits and answer any questions you may have
  • If eligible, send you a welcome letter with a program card

At time of treatment, your infusion provider will:

  • Submit a claim for medication and infusion costsd to your primary health insurance plan
  • Complete and submit a reimbursement claim for your applicable out-of-pocket costs using your program card

Searchlight Support® will issue payment to your infusion provider following validation of all required claim information, including the Explanation of Benefits (EOB) from your health plan.

If you’ve already paid your out-of-pocket costs to your infusion provider for costs related to your treatment OR to a specialty pharmacy for the cost of RADICAVA®, complete and submit a Request for Out-of-Pocket Assistance Form, along with the required EOB or pharmacy receipt.

You may receive a check for applicable out-of-pocket costs following validation of all required claim information. Requests must be submitted within 365 days of the date of service.

dPersons residing in Massachusetts, Minnesota, Michigan, and Rhode Island are eligible for out-of-pocket assistance for the cost of the drug only and are not eligible for other types of cost support for administration of the medication.

Restrictions apply. See Eligibility Requirements & Terms and Conditions.

Out-of-Pocket Assistance Program Enrollment Form

Ask your healthcare provider if they have or will be submitting a Benefit Investigation and Enrollment Form for RADICAVA®. If not, you can also enroll by completing and submitting the Out-of-Pocket Assistance Program Enrollment Form.

Request for Out-of-Pocket Assistance Form

Use this form if you are enrolled in the Out-of-Pocket Assistance Program and have already paid your out-of-pocket costs to your infusion provider for costs related to your treatment or to a specialty pharmacy for the cost of RADICAVA®.

Resources for patients who are uninsured

The Searchlight Support® Patient Assistance Program (PAP) can help uninsured patients who are in financial need. Patients who meet Program requirements may be able to receive medication at no charge for up to 2 years. The patient must be a citizen or a permanent resident of the US or its territories, and reside in the US or its territories. The patient's income must not exceed 5 times the Federal Poverty Level based on household size (Federal Poverty Level Guidelines are available at https://aspe.hhs.gov/poverty-guidelines).

How this program works
  1. You and your doctor complete the Benefit Investigation and Enrollment Form and submit to Searchlight Support® with all required documentation.
  2. If you meet the Patient Assistance Program requirements, the program will cover your RADICAVA® medication as prescribed by your HCP at no charge for one year.e
  3. You must reconfirm your eligibility for continued participation in the program after your initial 12-month eligibility period by providing required financial documentation.
  4. If you continue to meet the program requirements, you may be able to receive RADICAVA® at no charge for an additional 12 months.

eOnly product provided at no charge. The Patient Assistance Program covers only the cost of RADICAVA® and not the cost of any infusion services or healthcare provider visits, which are the sole responsibility of the patient.

Restrictions apply. See Eligibility Requirements & Terms and Conditions.

Alternate Support/Resource Information

Below, please find some resources that may provide more support for you and your loved ones.

Mitsubishi Tanabe Pharma America, Inc. is not affiliated with these resource organizations, which may have their own eligibility criteria and evaluation processes. By listing these resource organizations, Mitsubishi Tanabe Pharma America, Inc. is not endorsing any particular service or group and is not responsible for the content of these sites or services. These resource organizations are provided here for informational purposes and are not meant to replace your healthcare provider’s medical advice.

ALS Association Assistance Program

www.alsa.org/als-care/

800-782-4747

Healthwell Foundation

www.healthwellfoundation.org

800-675-8416

Patient Services Incorporated (PSI)

www.patientservicesinc.org

800-366-7741

2021 Open Enrollment Information for Patients

The 2021 Open Enrollment Information for Patients brochure is designed to help you understand general coverage options, even if infusions are received at multiple locations, such as at a doctor’s office, an infusion center, a hospital outpatient department, or at home. During Open Enrollment, you can review your insurance coverage and make changes, or you can choose a new plan. Since this brochure does not include a complete list of health plan options, please contact your health insurance company or medicare.gov for specific information.

To learn more, download the 2021 Open Enrollment Information for Patients brochure. If you have questions, please call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

ALS Care Locator

The ALS Care Locator is designed for the ALS community to help locate services for the treatment of ALS. It can help you:

  • Search for infusion services capable of administering RADICAVA®, including home infusion, based on your preferences; for example:
    • Type of facility, location, insurance accepted, including Medicare
    • Languages spoken, hours of operation, amenities
  • Find neurologists and other healthcare providers who treat ALS

Visit radicava.com/carelocator for more information, or to start a search now.f

The ALS Care Locator is an informational resource only regarding available treatment providers. The providers listed in the directory are under no obligation to provide treatment.

f The ALS Care Locator is a directory with a number of functions, including a directory of providers that treat ALS and which have opted-in to participate in the directory. This submission information is updated on a monthly basis.

Providers listed in the directory are not affiliated with Mitsubishi Tanabe Pharma America, Inc. and do not pay to be on this list. No fees or remuneration of any kind have been or will be exchanged for participation in the ALS Care Locator. Inclusion of a provider in the ALS Care Locator does not constitute a referral, recommendation, endorsement, or verification of credentials, qualifications, or abilities of the provider listed. Similarly, the absence of a provider's name and information should not be construed as a negative comment from Mitsubishi Tanabe Pharma America, Inc. about the provider's credentials, qualifications, or abilities.

Mitsubishi Tanabe Pharma America, Inc., as well as its employees or agents, shall not be held liable for any damages or harm resulting from any use or reliance on information contained in the ALS Care Locator; and may modify, amend, remove or cancel the ALS Care Locator at any time without notice.

If you are an HCP who treats ALS, including a neurologist and those at a multidisciplinary center, and would like to be added to the ALS Care Locator, please contact LocatorQuestions@mt-pharma-us.com, or if you would like to be removed from the ALS Care Locator, please contact LocatorOptOut@mt-pharma-us.com.

If you are an infusion service provider who has experience administering RADICAVA® and would like to be added to the ALS Care Locator, or if you are listed in the ALS Care Locator and would like to be removed, please contact Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

Searchlight Support® FAQs

Who can use Searchlight Support®?

To help people with ALS access treatment with RADICAVA®, Searchlight Support® offers programs and assistance for healthcare providers and people who receive RADICAVA®. Caregivers may also seek support on behalf of a loved one who receives RADICAVA®.

For questions about how Searchlight Support® can help, call at Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

How do I enroll for help from Searchlight Support®?

To be enrolled in Searchlight Support®, your healthcare provider must order RADICAVA® for you. You will also need to sign a form to authorize your enrollment in the program.

Can I get help paying for RADICAVA®?

Searchlight Support® can give you information about out-of-pocket cost support programs and other sources of financial assistance that may be available to you.

If your healthcare provider includes all of the details needed when they first order RADICAVA® for you, you may be automatically enrolled in the Searchlight Support® Out-of-Pocket Assistance Program if you are eligible. If you are in financial need and have no insurance, you may be eligible for the Patient Assistance Program.

For questions about out-of-pocket cost support, call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

What can I do if my insurance company denies coverage for RADICAVA®?

Your insurance company may initially deny your treatment with RADICAVA®. If this happens, you may be able to do something about it. Here are some ideas you may find helpful:

  • Talk to your healthcare provider (HCP) and call your insurance provider to request an “exception” for coverage of your medication

    If you have been notified that your medication is not covered by your health plan or that you need to meet other requirements before obtaining it, you can call your insurance provider and request an “exception” for coverage of your medication.

    Review this guide for some helpful steps you may follow: Requesting an Exception from Your Health Plan.

  • Talk to your HCP to see if it may be possible to file an appeal

    If your request for an exception is denied you may be able to appeal the decision.

    Having your HCP file an appeal may help give your insurance provider more details about why you should receive treatment.

    If the appeal does not work, your HCP may request a next-level appeal. Some of the people that may be involved include a panel of HCPs, an administrative judge, or a local state representative.

  • Consider other insurance plan options

    For example, if you have been diagnosed with ALS, even if you are under 65, you may be eligible for Medicare or Social Security Disability Insurance (SSDI).

    For questions about appeals or insurance coverage, call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548) to learn more.

What can I do if I am denied infusion by a site of care?

If your preferred site of care is unable to accommodate you, our ALS Care Locator may help identify another infusion provider. Visit radicava.com/carelocator or call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548) to learn more.

How do I renew my eligibility for out-of-pocket support into 2020?

Completion of the Verification of Patient Insurance Form is required to confirm your continued eligibility for the Searchlight Support® Out-of-Pocket Assistance Program and to process 2020 reimbursement claims. Please complete and fax this form to 1-888-782-6157 or submit to Searchlight Support®, PO Box 2930, Phoenix, AZ 85062.

To learn more, call 1-844-SRCHLGT (1-844-772-4548).

The information and advice provided here are general in nature and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. You are strongly encouraged to seek the advice of your doctor or other qualified healthcare provider with any questions regarding a medical condition.

Important Safety Information

Before you receive Radicava® (edaravone), tell your healthcare provider about all of your medical conditions, including if you:

  • have asthma.
  • are allergic to other medicines.
  • are pregnant or plan to become pregnant. It is not known if Radicava® will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Radicava® passes into your breastmilk. You and your healthcare provider should decide if you will receive Radicava® or breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Radicava®?

  • Radicava® may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.
  • Hypersensitivity reactions have happened in people receiving Radicava® and can happen after your infusion is finished.
  • Radicava® contains sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
  • Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).
  • Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects.

The most common side effects of Radicava® include bruising (contusion), problems walking (gait disturbance), and headache.

These are not all the possible side effects of Radicava®. Call your healthcare provider for medical advice about side effects. You may report side effects to Mitsubishi Tanabe Pharma America, Inc. at 1-888-292-0058 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Indication

Radicava® is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Please see full Prescribing Information and Patient Information.

For more information about RADICAVA®, call 1-844-SRCHLGT ( 1-844-772-4548).